PFN1 and amyotrophic lateral sclerosis: This study provides strong evidence that binding of the ALS-associated PFN1 T109M mutant protein to actin is not impaired and that this mutation has no effect on the actin cytoskeleton, suggesting additional or alternative mechanisms for PFN1-linked neurodegeneration beyond an impairment of cytoskeletal dynamics.